Abcuro
Armando Reyes is Abcuro’s Associate Director of Clinical Operations. He has over 17 years working in Industry, with the past 14 years fulfilling a variety of leadership roles, working for CROs and Sponsors. Most recently, he was Senior Manager and the Global Operational Lead on a 26-country program with Allergan/AbbVie. He has executed a variety of global, multi-center clinical trials, in all phases of research in a variety of therapeutic areas such as Cardiology, Hepatology, Gastroenterology, Endocrinology, Dermatology, Oncology, CNS, Immunology, and Infectious Disease. Armando received his B.Sc. degree from Averett University.
This person is not in any offices
Abcuro
2 followers
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies.